Galectin Therapeutics Inc (NASDAQ:GALT)

4.56
Delayed Data
As of May 18
 +0.18 / +4.11%
Today’s Change
1.28
Today|||52-Week Range
6.74
+36.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization10.0K7.0K7.0K1.0K
 
 
 
 
 
 
Operating ExpensesGross Income-10.0K-7.0K-7.0K-1.0K
 
 
 
 
 
General Expenses15.3M20.1M21.5M16.2M
 
 
 
 
 
Research And Development8.4M13.1M15.3M11.7M
 
 
 
 
 
Total Operating Expenses15.3M20.1M21.5M16.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.3M-20.1M-21.5M-16.2M
 
 
 
 
 
Extraordinary Charge-150.0K0.000.000.00
 
 
Pre-Tax Equity Earnings-400.0K0.000.000.00
 
 
Other Expenses0.000.000.00-12.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-15.8M-20.0M-21.4M-16.2M
 
 
 
 
 
Preferred Dividend-943.0K-1.1M-914.0K-1.2M
 
 
 
 
 
Net Income-16.0M-20.0M-21.4M-16.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.8M24.1M29.2M35.5M
 
 
 
 
 
Shares To Calculate EPS Diluted21.8M24.1M29.2M35.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.78-$0.88-$0.76-$0.49
 
 
 
 
 
EPS Diluted-$0.78-$0.88-$0.76-$0.49